UnknownNot Applicable

Prevalence Study of Amyloidosis in Patients With Surgery of Suspect Bilateral Carpal Tunnel (AMYLYONCARP)

France100 participantsStarted 2021-05-17

Plain-language summary

The purpose of this study is to evaluate the prevalence of amyloidosis in population of patient affected by suspect bilateral carpal tunnel with indication of surgery

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * bilateral carpal tunnel with indication of surgery and judged suspect: * age of 50 years old and more * non-traumatic or undetermined neuropathic etiology or cardiac history (atrial arrhythmia or Heart Failure or cardiac stimulation) or family history of hereditary amyloidosis or monoclonal gammopathy Exclusion Criteria: * patient with diagnosis of amyloidosis * traumatic bilateral carpal tunnel or linked to rheumatoid arthritis

What they're measuring

Prevalence of amyloid aggregate

Timeframe: During surgery

Trial details

NCT IDNCT04890119

SponsorCentre Hospitalier Saint Joseph Saint Luc de Lyon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06

Contact for this trial

Philippe SCHIELE, MD

478 618 216 pschiele@chsjsl.fr

View on ClinicalTrials.gov More Carpal Tunnel Syndrome Bilateral trials